Boyd Watterson Asset Management LLC OH reduced its position in shares of Cigna Group (NYSE:CI – Free Report) by 10.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,003 shares of the health services provider’s stock after selling 450 shares during the period. Boyd Watterson Asset Management LLC OH’s holdings in Cigna Group were worth $1,323,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of CI. Brighton Jones LLC lifted its position in shares of Cigna Group by 9.3% during the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Cigna Group by 6.2% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,888 shares of the health services provider’s stock worth $11,990,000 after purchasing an additional 2,143 shares during the last quarter. Sunbelt Securities Inc. lifted its position in Cigna Group by 27.6% in the first quarter. Sunbelt Securities Inc. now owns 222 shares of the health services provider’s stock valued at $73,000 after acquiring an additional 48 shares during the last quarter. Sovran Advisors LLC purchased a new stake in Cigna Group in the first quarter valued at $214,000. Finally, Avidian Wealth Enterprises LLC lifted its position in Cigna Group by 5.1% in the first quarter. Avidian Wealth Enterprises LLC now owns 3,821 shares of the health services provider’s stock valued at $1,257,000 after acquiring an additional 184 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Cigna Group
In other news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares in the company, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.
Cigna Group Price Performance
Cigna Group (NYSE:CI – Get Free Report) last announced its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. During the same period in the prior year, the company earned $6.72 earnings per share. The business’s revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts predict that Cigna Group will post 29.77 EPS for the current year.
Cigna Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Thursday, December 4th. Cigna Group’s payout ratio is 32.97%.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the stock. Wolfe Research reduced their price target on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. Barclays boosted their price target on shares of Cigna Group from $354.00 to $383.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. Cantor Fitzgerald reissued an “overweight” rating and issued a $365.00 price target on shares of Cigna Group in a research report on Tuesday, August 26th. Truist Financial set a $375.00 price target on shares of Cigna Group in a research report on Tuesday, September 2nd. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $369.89.
Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading
- Five stocks we like better than Cigna Group
- Why Are These Companies Considered Blue Chips?
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- What is Forex and How Does it Work?
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- A Deeper Look at Bid-Ask Spreads
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
